145 related articles for article (PubMed ID: 33240563)
1. Adverse Pregnancy Outcomes by Degree of Maternal Serum Analyte Elevation: A Retrospective Cohort Study.
Yeaton-Massey A; Baer RJ; Rand L; Jelliffe-Pawlowski LL; Lyell DJ
AJP Rep; 2020 Oct; 10(4):e369-e379. PubMed ID: 33240563
[No Abstract] [Full Text] [Related]
2. Obstetrical complications associated with abnormal maternal serum markers analytes.
Gagnon A; Wilson RD;
J Obstet Gynaecol Can; 2008 Oct; 30(10):918-932. PubMed ID: 19038077
[TBL] [Abstract][Full Text] [Related]
3. [Predictive value of abnormal second-trimester maternal serum triple screening markers for adverse pregnancy outcomes].
Hu Z; Liu X; Li L; Jia C; Li D; Liu R
Zhonghua Fu Chan Ke Za Zhi; 2014 Oct; 49(10):749-53. PubMed ID: 25537246
[TBL] [Abstract][Full Text] [Related]
4. The impact of fresh versus frozen-thawed embryos on maternal serum analyte levels in IVF singleton and twin pregnancies.
Peyser A; Gulersen M; Krantz D; Li X; Bornstein E; Rochelson B; Mullin C; Goldman R
J Assist Reprod Genet; 2024 Feb; 41(2):473-481. PubMed ID: 38133878
[TBL] [Abstract][Full Text] [Related]
5. Mid-trimester maternal serum AFP and hCG as markers of preterm and term adverse pregnancy outcomes.
Tancrède S; Bujold E; Giguère Y; Renald MH; Girouard J; Forest JC
J Obstet Gynaecol Can; 2015 Feb; 37(2):111-6. PubMed ID: 25767942
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of Maternal Serum sHLA-G Levels for Trisomy 18 Fetuses Screening at Second Trimester.
Xu D; Zhu Y; Li L; Xu Y; Yan W; Dai M; Gan L
Front Genet; 2020; 11():497264. PubMed ID: 33574829
[TBL] [Abstract][Full Text] [Related]
7. [Early warning of low maternal unconjugated estriol level by prenatal screening for fetus with X-linked ichthyosis].
Liu HY; Li J; Huang DR; Feng K; Liu JH; He QN; Guo KY; Ding GY; Lou Y; Wang Y
Zhonghua Fu Chan Ke Za Zhi; 2022 Jun; 57(6):407-412. PubMed ID: 35775247
[No Abstract] [Full Text] [Related]
8. Association Analysis between Maternal Serum Biomarkers and Fetal Congenital Heart Disease.
Jiang H; Lin Y; He X
Heart Surg Forum; 2023 Oct; 26(5):E552-E559. PubMed ID: 37920073
[TBL] [Abstract][Full Text] [Related]
9. Midtrimester maternal serum screening after multifetal pregnancy reduction in pregnancies conceived by in vitro fertilization.
Rotmensch S; Celentano C; Shalev J; Vishne TH; Lipitz S; Ben-Rafael Z; Glezerman M
J Assist Reprod Genet; 1999 Jan; 16(1):8-12. PubMed ID: 9987687
[TBL] [Abstract][Full Text] [Related]
10. Association between aneuploidy screening analytes and adverse outcomes in twin gestations.
Yamasato K; Ono A
J Perinat Med; 2024 Apr; ():. PubMed ID: 38634781
[TBL] [Abstract][Full Text] [Related]
11. The association of triple-marker test results with adverse pregnancy outcomes in low-risk pregnancies with healthy newborns.
Sayin NC; Canda MT; Ahmet N; Arda S; Süt N; Varol FG
Arch Gynecol Obstet; 2008 Jan; 277(1):47-53. PubMed ID: 17653738
[TBL] [Abstract][Full Text] [Related]
12. Multiple marker second trimester serum screening for pre-eclampsia.
Wald NJ; Morris JK
J Med Screen; 2001; 8(2):65-8. PubMed ID: 11480445
[TBL] [Abstract][Full Text] [Related]
13. The impact of preimplantation genetic testing on first- and second-trimester maternal serum analyte levels.
Gulersen M; Krantz D; Li X; Peyser A; Goldman R; Mullin C; Bornstein E; Rochelson B
J Matern Fetal Neonatal Med; 2022 Dec; 35(26):10435-10443. PubMed ID: 36195461
[TBL] [Abstract][Full Text] [Related]
14. Preliminary evidence for associations between second-trimester human chorionic gonadotropin and unconjugated oestriol levels with pregnancy outcome in Down syndrome pregnancies.
Benn PA
Prenat Diagn; 1998 Apr; 18(4):319-24. PubMed ID: 9602476
[TBL] [Abstract][Full Text] [Related]
15. Human chorionic gonadotropin and unconjugated oestriol measurements in insulin-dependent diabetic pregnant women being screened for fetal Down syndrome.
Palomaki GE; Knight GJ; Haddow JE
Prenat Diagn; 1994 Jan; 14(1):65-8. PubMed ID: 7514290
[TBL] [Abstract][Full Text] [Related]
16. Serum markers for Down's syndrome in relation to number of previous births and maternal age.
Wald NJ; Watt HC
Prenat Diagn; 1996 Aug; 16(8):699-703. PubMed ID: 8878278
[TBL] [Abstract][Full Text] [Related]
17. Abnormal second-trimester serum analytes are more predictive of preterm preeclampsia.
Olsen RN; Woelkers D; Dunsmoor-Su R; Lacoursiere DY
Am J Obstet Gynecol; 2012 Sep; 207(3):228.e1-7. PubMed ID: 22818876
[TBL] [Abstract][Full Text] [Related]
18. The use of free beta-hCG in antenatal screening for Down's syndrome.
Wald N; Densem J; Stone R; Cheng R
Br J Obstet Gynaecol; 1993 Jun; 100(6):550-7. PubMed ID: 7687460
[TBL] [Abstract][Full Text] [Related]
19. Elevated second-trimester maternal serum β-human chorionic gonadotropin and amniotic fluid alpha-fetoprotein as indicators of adverse obstetric outcomes in fetal Turner syndrome.
Alvarez-Nava F; Soto M; Lanes R; Pons H; Morales-Machin A; Bracho A
J Obstet Gynaecol Res; 2015 Dec; 41(12):1891-8. PubMed ID: 26369382
[TBL] [Abstract][Full Text] [Related]
20. Maternal serum unconjugated oestriol and human chorionic gonadotrophin levels in pregnancies with insulin-dependent diabetes: implications for screening for Down's syndrome.
Wald NJ; Cuckle HS; Densem JW; Stone RB
Br J Obstet Gynaecol; 1992 Jan; 99(1):51-3. PubMed ID: 1372176
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
